CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL
Abstract It was previously believed that patients with Ph-like ALL had poorer prognosis compared with other B-ALL subgroups due to resistance to conventional chemotherapy and lack of targeted drugs. CAR-T therapy has been successfully applied in the treatment of relapsed and refractory B-ALL. Curren...
Saved in:
Main Authors: | Hai-ping Dai (Author), Dan-qing Kong (Author), Hong-jie Shen (Author), Wei Cui (Author), Qian Wang (Author), Zheng Li (Author), Jia Yin (Author), Li-qing Kang (Author), Lei Yu (Author), De-pei Wu (Author), Xiao-wen Tang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report
by: Meng-Yun Li, et al.
Published: (2020) -
Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
Published: (2020) -
Allogeneic hematopoietic stem cell transplantation in mycosis fungoides
by: Angelo Atalla, et al.
Published: (2013) -
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
by: Solange dos Santos Moragas Barbosa, et al.
Published: (2014) -
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
by: Solange dos Santos Moragas Barbosa, et al.
Published: (2014)